South and Central America Neuromodulation Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. South and Central America Neuromodulation Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. South and Central America Neuromodulation Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. South and Central America Neuromodulation Market Regional Analysis

6.2 South and Central America Neuromodulation Market Revenue 2017-2027 (US$ Million)

6.3 South and Central America Neuromodulation Market Forecast Analysis

7. South and Central America Neuromodulation Market Analysis – by Technology

7.1 External Neuromodulation

7.1.1 Overview
7.1.2 External Neuromodulation: South and Central America Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.2 Internal Neuromodulation

7.2.1 Overview
7.2.2 Internal Neuromodulation: South and Central America Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)

8. South and Central America Neuromodulation Market Analysis – by Application

8.1 Chronic Pain Management

8.1.1 Overview
8.1.2 Chronic Pain Management: South and Central America Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.2 Failed Back Syndrome

8.2.1 Overview
8.2.2 Failed Back Syndrome: South and Central America Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.3 Epilepsy

8.3.1 Overview
8.3.2 Epilepsy: South and Central America Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.4 Tremor

8.4.1 Overview
8.4.2 Tremor: South and Central America Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.5 Incontinence

8.5.1 Overview
8.5.2 Incontinence: South and Central America Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.6 Depression

8.6.1 Overview
8.6.2 Depression: South and Central America Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.7 Dystonia

8.7.1 Overview
8.7.2 Dystonia: South and Central America Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.8 Gastroparesis

8.8.1 Overview
8.8.2 Gastroparesis: South and Central America Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.9 Parkinson's Disease

8.9.1 Overview
8.9.2 Parkinson's Disease: South and Central America Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.10 Obsessive-Compulsive Disorder

8.10.1 Overview
8.10.2 Obsessive-Compulsive Disorder: South and Central America Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.11 Migraine

8.11.1 Overview
8.11.2 Migraine: South and Central America Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)

9. South and Central America Neuromodulation Market Analysis – by End User

9.1 Hospitals

9.1.1 Overview
9.1.2 Hospitals: South and Central America Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.2 Clinics

9.2.1 Overview
9.2.2 Clinics: South and Central America Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.3 Home Healthcare

9.3.1 Overview
9.3.2 Home Healthcare: South and Central America Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)

10. South and Central America Neuromodulation Market – South and Central America Analysis

10.1 Overview

10.2 South and Central America

10.2.1 South and Central America Neuromodulation Market Breakdown, by Key Country, 2020 and 2027 (%)
10.2.1.1 South and Central America Neuromodulation Market – Revenue and Forecast Analysis – by Country
10.2.1.1 Brazil: South and Central America Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.1.1 Brazil: South and Central America Neuromodulation Market Breakdown, by Technology
10.2.1.1.2 Brazil: South and Central America Neuromodulation Market Breakdown, by Application
10.2.1.1.3 Brazil: South and Central America Neuromodulation Market Breakdown, by End User

10.2.1.2 Argentina: South and Central America Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.2.1 Argentina: South and Central America Neuromodulation Market Breakdown, by Technology
10.2.1.2.2 Argentina: South and Central America Neuromodulation Market Breakdown, by Application
10.2.1.2.3 Argentina: South and Central America Neuromodulation Market Breakdown, by End User

10.2.1.3 Rest of South and Central America : South and Central America Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.3.1 Rest of South and Central America : South and Central America Neuromodulation Market Breakdown, by Technology
10.2.1.3.2 Rest of South and Central America : South and Central America Neuromodulation Market Breakdown, by Application
10.2.1.3.3 Rest of South and Central America : South and Central America Neuromodulation Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Abbott

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Boston Scientific Corporation

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Medtronic

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 NeuroPace, Inc.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 NeuroSigma, Inc.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 NEVRO CORP.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Synapse Biomedical Inc.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Soterix Medical Inc.

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Integer Holdings Corporation

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Magstim

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

South and Central America Neuromodulation Market